Full Text View
Tabular View
No Study Results Posted
Related Studies
Study to Evaluate Imatinib in Desmoid Tumors
This study is currently recruiting participants.
Verified January 2012 by University of Heidelberg
Study NCT01137916   Information provided by University of Heidelberg

First Received on June 2, 2010.   Last Updated on January 3, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Aggressive Fibromatosis
Desmoid Tumor
Additional conditions recognized in this trial
Aggression
Fibroma
Fibromatosis, Aggressive
More general conditions related to this trial
Behavioral Symptoms
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Connective and Soft Tissue
Neoplasms, Connective Tissue
Neoplasms, Fibrous Tissue
Interventions listed in this trial
Imatinib
More general drug interventions related to this trial
Antineoplastic Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protein Kinase Inhibitors
Therapeutic Uses
Sponsors listed in this trial
University of Heidelberg
Novartis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services